Given the far-reaching contributions of BAF complexes during neural development and beyond, it is not surprising that mutations targeting their subunits perturb normal brain function. With the advent of next-generation sequencing, a host of BAF mutations have been discovered in human neurological disorders ranging from syndromic and non-syndromic intellectual disability to psychiatric conditions and neurodegenerative disease (Figure 2).
